Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development

By Mori K.   Hashimoto H.   Takatsu H.   Tsuda-Tsukimoto M.   Kume T.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 415-422

Informa Healthcare

Access to resources Recommend Favorite

Mechanism-Based Inactivation of Cytochromes P450 2E1 and 2B1 by 5-Phenyl-1-pentyne

By Roberts E.S.   Alworth W.L.   Hollenberg P.F.  

Archives of Biochemistry and Biophysics, Vol. 354, Iss. 2, 1998-06 ,pp. : 295-302

Elsevier

Access to resources Recommend Favorite

Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel

By Nishiya Y.   Hagihara K.   Kurihara A.   Okudaira N.   Farid N.A.   Okazaki O.   Ikeda T.  

Xenobiotica, Vol. 39, Iss. 11, 2009-11 ,pp. : 836-843

Informa Healthcare

Access to resources Recommend Favorite

Mechanism-based Inhibition of C5-cytosine DNA Methyltransferases by 2-H Pyrimidinone

By Hurd P.J.   Whitmarsh A.J.   Baldwin G.S.   Kelly S.M.   Waltho J.P.   Price N.C.   Connolly B.A.   Hornby D.P.  

Journal of Molecular Biology, Vol. 286, Iss. 2, 1999-02 ,pp. : 389-401

Academic Press

Access to resources Recommend Favorite

Mechanism-based inhibition of CYP activities in rat liver by fluoxetine and structurally similar alkylamines

By Murray M.   Murray K.  

Xenobiotica, Vol. 33, Iss. 10, 2003-10 ,pp. : 973-987

Informa Healthcare

Access to resources Recommend Favorite